Entry |
|
Name |
Senega syrup (JP18); Senega syrup (TN) |
Component |
Senegin II [CPD: C08978], (Senegin III [CPD: C17760] | Senegin IV [CPD: C17761]), (Methyl salicylate [CPD: C12305] | Fatty oil)
|
Source |
|
Remark |
Therapeutic category: | 2231 |
Product (DG01067): | D06747<JP> D04326<JP> |
|
Efficacy |
Expectorant |
Comment |
Major component: Senegin [CPD: C08978]
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
R RESPIRATORY SYSTEM
R05 COUGH AND COLD PREPARATIONS
R05C EXPECTORANTS, EXCL. COMBINATIONS WITH COUGH SUPPRESSANTS
R05CA Expectorants
R05CA06 Senega
D04326 Senega syrup (JP18) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
22 Respiratory organ agents
223 Expectorants
2231 Phytochemical agents
D04326 Senega syrup (JP18)
Crude drugs [BR:br08305]
Dicot plants: rosids
Polygalaceae (milkwort family)
D04326 Senega syrup
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
Crude drugs
D04326 Senega syrup
|
Other DBs |
|